From small ions to large molecules, cellular gates control what can pass in and out of cells. But how one such gate, called ...

Only 6% of trials for FDA-approved drugs match America's diversity. Analysis reveals how trial location and design choices ...

This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...

The time of day that cancer drugs are administered could make a big difference to a patient's outcomes, and would be a ...

In the 21st century, oncology has achieved extraordinary progress. We can decode a tumor’s genome, tailor therapies to ...

Montara’s BrainOnly platform is designed to prevent peripheral side effects and concentrate neurological drugs’ activity in the brain via ...

Clinicians and health system leaders met in Portland, Oregon, on October 21, 2025, to discuss the evolving options for treating Alzheimer disease and multiple sclerosis.

The global digestive health market is booming, valued at $51bn (€43bn) and projected to reach $68bn by 2030 with an 8.3% CAGR ...

Bruker's Acquifer Imaging Machine (IM) is a fully automated widefield microscope with both brightfield and fluorescence ...

Company addresses FDA requests regarding formulation excipient – Global site start-up activities continue, with first-patient-in for ...

Resistant hypertension remains a tough adversary in the fight against the global rise of cardiovascular disease, but updated ...

The field of dermatology has witnessed remarkable progress in the prevention and treatment of skin diseases over the past ...